Inactive Instrument

GenMark Diagnostics, Inc.

Equities

GNMK

US3723091043

Advanced Medical Equipment & Technology

GenMark Diagnostics, Inc. Provides Financial Guidance for the Third Quarter Ended September 30, 2020

October 08, 2020 at 04:03 pm

GenMark Diagnostics, Inc. provided financial guidance for the third quarter ended September 30, 2020. Total revenue expected to be approximately $42.6 million, representing an increase of 104% over the third quarter of 2019.

Latest news about GenMark Diagnostics, Inc.

GenMark Diagnostics, Inc. Announces Executive Changes	21-04-22	CI
Roche : Secures 83% Acceptances In $1.8 Billion Tender Offer For GenMark Diagnostics	21-04-22	MT
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P Global BMI Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P TMI Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P Healthcare Equipment Select Industry Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000 Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Small Cap Completeness Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Small Cap Comp Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000 Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Microcap Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000E Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000E Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Microcap Growth Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Dynamic Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Dynamic Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Growth-Dynamic Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Growth-Dynamic Index	21-04-22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from NASDAQ Composite Index	21-04-22	CI
Roche Holding AG completed the acquisition of GenMark Diagnostics, Inc..	21-04-20	CI
Insider Trends: GenMark Diagnostics Insider Exercises Options Extending 90-Day Buying Trend	21-04-16	MT
Roche : U.S. lab products provider Avantor to buy Germany's Ritter for $1.1 bln	21-04-12	RE

Chart GenMark Diagnostics, Inc.

Duration

Period

More charts

Company Profile

GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers four Food and Drug Administration (FDA)-cleared diagnostic tests which run on its XT-8 instrument; its Respiratory Viral Panel; its Cystic Fibrosis Genotyping Test; its Warfarin Sensitivity Test, and its Thrombophilia Risk Test. It also offers a Hepatitis C (HCV) genotyping test and associated custom manufactured reagents, as well as a 2C19 Genotyping Test, versions of which are available for use with its XT-8 instrument for research use only (RUO). Its XT-8 and ePlex test cartridges utilize the combination of distinct electrodes and multiple signal probes to detect dozens of target biomarkers from a single sample, thereby enabling highly multiplexed testing.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+6.88%	219B
DANAHER CORPORATION	+10.63%	192B
INTUITIVE SURGICAL, INC.	+18.16%	142B
BOSTON SCIENTIFIC CORPORATION	+29.70%	111B
SIEMENS HEALTHINEERS AG	+2.09%	65.32B
EDWARDS LIFESCIENCES CORPORATION	+14.14%	52.45B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.01%	49.8B
AGILENT TECHNOLOGIES, INC.	+4.64%	43.43B
GE HEALTHCARE TECHNOLOGIES INC.	+1.45%	35.95B

Other Advanced Medical Equipment & Technology